Cargando…
Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or l...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594222/ https://www.ncbi.nlm.nih.gov/pubmed/30720903 http://dx.doi.org/10.1111/jdv.15475 |
_version_ | 1783430206672863232 |
---|---|
author | Howells, L. Thomas, K.S. Sears, A.V. Nasr, I. Wollenberg, A. Schuttelaar, M.L.A. Romeijn, G.L.E. Paller, A.S. Mueller, K. Doytcheva, K. Kataoka, Y. Daguze, J. Barbarot, S. von Kobyletzki, L.B. Beckman, L. Ratib, S. Cowdell, F. Santer, M. Chalmers, J.R. |
author_facet | Howells, L. Thomas, K.S. Sears, A.V. Nasr, I. Wollenberg, A. Schuttelaar, M.L.A. Romeijn, G.L.E. Paller, A.S. Mueller, K. Doytcheva, K. Kataoka, Y. Daguze, J. Barbarot, S. von Kobyletzki, L.B. Beckman, L. Ratib, S. Cowdell, F. Santer, M. Chalmers, J.R. |
author_sort | Howells, L. |
collection | PubMed |
description | BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. OBJECTIVES: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. METHODS: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. RESULTS: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty‐two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. CONCLUSIONS: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions. |
format | Online Article Text |
id | pubmed-6594222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65942222019-07-10 Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema Howells, L. Thomas, K.S. Sears, A.V. Nasr, I. Wollenberg, A. Schuttelaar, M.L.A. Romeijn, G.L.E. Paller, A.S. Mueller, K. Doytcheva, K. Kataoka, Y. Daguze, J. Barbarot, S. von Kobyletzki, L.B. Beckman, L. Ratib, S. Cowdell, F. Santer, M. Chalmers, J.R. J Eur Acad Dermatol Venereol Allergy and Eczema BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. OBJECTIVES: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. METHODS: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. RESULTS: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty‐two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. CONCLUSIONS: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions. John Wiley and Sons Inc. 2019-04-08 2019-06 /pmc/articles/PMC6594222/ /pubmed/30720903 http://dx.doi.org/10.1111/jdv.15475 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Allergy and Eczema Howells, L. Thomas, K.S. Sears, A.V. Nasr, I. Wollenberg, A. Schuttelaar, M.L.A. Romeijn, G.L.E. Paller, A.S. Mueller, K. Doytcheva, K. Kataoka, Y. Daguze, J. Barbarot, S. von Kobyletzki, L.B. Beckman, L. Ratib, S. Cowdell, F. Santer, M. Chalmers, J.R. Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title | Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title_full | Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title_fullStr | Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title_full_unstemmed | Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title_short | Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
title_sort | defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema |
topic | Allergy and Eczema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594222/ https://www.ncbi.nlm.nih.gov/pubmed/30720903 http://dx.doi.org/10.1111/jdv.15475 |
work_keys_str_mv | AT howellsl definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT thomasks definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT searsav definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT nasri definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT wollenberga definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT schuttelaarmla definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT romeijngle definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT palleras definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT muellerk definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT doytchevak definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT kataokay definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT daguzej definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT barbarots definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT vonkobyletzkilb definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT beckmanl definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT ratibs definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT cowdellf definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT santerm definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT chalmersjr definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema AT definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema |